Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Sharp, Andrew N ^a   Heazell, Alexander E P ^a   Baczyk, Dora ^b   Dunk, Caroline E ^b   Lacey, Helen A ^a   Jones, Carolyn J P ^b   Perkins, Jonathan E ^b   Kingdom, John C P ^b   Baker, Philip N ^a,c   Crocker, Ian P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; MESSENGER RNA; NUTLIN 3; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; AUTOPHAGY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEGATIVE FEEDBACK; PREECLAMPSIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; WESTERN BLOTTING;

BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CHORIONIC VILLI; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84900414651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087621     Document Type: Article

References (86)

1. Campbell DM, MacGillivray I, Carr-Hill R (1985) Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 92: 131-140. (Pubitemid 15162717)
2. Xiong X, Fraser WD, Demianczuk NN (2002) History of abortion, preterm, term birth, and risk of preeclampsia: a population-based study. Am J Obstet Gynecol 187: 1013-1018. (Pubitemid 35178404)
3. Oh SY, Choi SJ, Kim KH, Cho EY, Kim JH, et al. (2008) Autophagy-related proteins, LC3 and Beclin-1, in placentas from pregnancies complicated by preeclampsia. Reprod Sci 15: 912-920.
4. Leung DN, Smith SC, To KF, Sahota DS, Baker PN (2001) Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184: 1249-1250. (Pubitemid 32434281)
5. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS (2009) Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30 Suppl A: S43-48.
6. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308: 1592-1594. (Pubitemid 40807500)
7. Myers JE, Baker PN (2002) Hypertensive diseases and eclampsia. Curr Opin Obstet Gynecol 14: 119-125. (Pubitemid 34267436)
8. Askelund KJ, Chamley LW (2011) Trophoblast deportation part I: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy. Placenta 32: 716-723.
9. Coleman SJ, Gerza L, Jones CJ, Sibley CP, Aplin JD, et al. (2013) syncytial nuclear aggregates in normal placenta show increased nuclear condensation, but apoptosis and cytoskeletal redistribution are uncommon. Placenta 34: 449-455.
10. Smith SC, Baker PN, Symonds EM (1997) Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 177: 57-65. (Pubitemid 27327311)
11. Huppertz B, Kingdom JC (2004) Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Investig 11: 353-362.
12. Crocker IP, Daayana SL, Baker PN (2004) An Image Analysis Technique for the Investigation of Human Placental Morphology in Pre-eclampsia and Intrauterine Growth Restriction. Journal of the Society for Gynecological Investigation 11: 545-552.
13. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol 96: 271-276. (Pubitemid 30447352)
14. Heazell AE, Buttle H, Baker PN, Crocker IP (2008) Altered Expression of Regulators of Caspase Activity within Trophoblast of Normal Pregnancies and Pregnancies Complicated by Pre-eclampsia. Reproductive Sciences 15: 1034-1043.
15. Jones CJ, Fox H (1980) An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1: 61-76. (Pubitemid 11240950)
16. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP (2007) Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta 28: S33-S40. (Pubitemid 46506047)
17. Sharp AN, Heazell AE, Crocker I, Mor G (2010) Placental apoptosis in health and disease. Am J Reprod Immunol 64: 159-169.
18. Heazell AE, Crocker IP (2008) Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 29: 772-783.
19. Hung TH, Burton GJ (2006) Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45: 189-200.
20. Heazell AE, Lacey HA, Jones CJ, Huppertz B, Baker PN, et al. (2008) Effects of Oxygen on Cell Turnover and Expression of Regulators of Apoptosis in Human Placental Trophoblast. Placenta 29: 175-186.
21. Soleymanlou N, Jurisicova A, Wu Y, Chijiiwa M, Ray JE, et al. (2007) Hypoxic switch in mitochondrial myeloid cell leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast cell death in preeclampsia. Am J Pathol 171: 496-506. (Pubitemid 47344682)
22. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, et al. (2002) Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 186: 1056-1061.
23. Hung TH, Chen SF, Lo LM, Li MJ, Yeh YL, et al. (2012) Increased autophagy in placentas of intrauterine growth-restricted pregnancies. PLoS One 7: e40957.
24. Hung TH, Chen SF, Liou JD, Hsu JJ, Li MJ, et al. (2008) Bax, Bak and mitochondrial oxidants are involved in hypoxia-reoxygenation-induced apoptosis in human placenta. Placenta 29: 565-583.
25. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112-126. (Pubitemid 29009841)
26. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825. (Pubitemid 23346378)
27. Gartel AL, Tyner AL (1999) Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246: 280-289. (Pubitemid 29393989)
28. Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N, et al. (2001) DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20: 3449-3455. (Pubitemid 32588994)
29. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Molecular Cell 7: 683-694. (Pubitemid 32706359)
30. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299. (Pubitemid 27220766)
31. Meek DW (2004) The p53 response to DNA damage. DNA Repair (Amst) 3: 1049-1056.
32. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
33. Heazell AE, Sharp AN, Baker PN, Crocker IP (2010) Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast. Apoptosis 16: 135-144.
34. Logan IR, McNeill HV, Cook S, Lu X, Lunec J, et al. (2007) Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells. Prostate 67: 900-906. (Pubitemid 46828944)
35. Coll-Mulet L, Iglesias-Serret D, Santidrian AF, Cosialls AM, de Frias M, et al. (2006) MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood 107: 4109-4114. (Pubitemid 43726820)
36. Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, et al. (2007) Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma. Clin Cancer Res 13: 3380-3387. (Pubitemid 46944926)
37. Stuhmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, et al. (2005) Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma. Blood 106: 3609-3617. (Pubitemid 41609200)
38. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science 303: 844-848. (Pubitemid 38174664)
39. Komarova E, Gudkov AV (1998) Could p53 be a target for therapeutic suppression? Seminars in Cancer Biology 8: 389-400. (Pubitemid 29131360)
40. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, et al. (1999) A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy. Science 285: 1733-1737. (Pubitemid 29428873)
41. Davey DA, MacGillivray I (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158: 892-898.
42. Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Gulmezoglu AM, et al. (2011) A global reference for fetal-weight and birthweight percentiles. Lancet 377: 1855-1861.
43. Baczyk D, Drewlo S, Proctor L, Dunk C, Lye S, et al. (2009) Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 16: 719-727.
44. Baczyk D, Kibschull M, Mellstrom B, Levytska K, Rivas M, et al. (2013) DREAM mediated regulation of GCM1 in the human placental trophoblast. PLoS One 8: e51837.
45. Martinez LA, Naguibneva I, Lehrmann H, Vervisch A, Tchenio T, et al. (2002) Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci U S A 99: 14849-14854. (Pubitemid 35334572)
46. Uchida C, Miwa S, Kitagawa K, Hattori T, Isobe T, et al. (2005) Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J 24: 160-169. (Pubitemid 40188473)
47. Lacey HA, Nolan T, Greenwood SL, Glazier JD, Sibley CP (2005) Gestational profile of Na+/H+ exchanger and Cl-/HCO3- anion exchanger mRNA expression in placenta using real-time QPCR. Placenta 26: 93-98. (Pubitemid 40123682)
48. Jones CJ, Mosley SM, Jeffrey IJ, Stoddart RW (1987) Elimination of the non-specific binding of avidin to tissue sections. Histochem J 19: 264-268.
49. Stoka V, Turk B, Schendel S, Kim T, Cirman T, et al. (2001) Lysosomal Protease Pathways to Apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 276: 3149-3157.
50. Kadyrov M, Kaufmann P, Huppertz B (2001) Expression of a cytokeratin 18 neo-epitope is a specific marker for trophoblast apoptosis in human placenta. Placenta 22: 44-48. (Pubitemid 32124095)
51. Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM (2012) Caspase-mediated apoptosis of trophoblasts in term human placental villi is restricted to cytotrophoblasts and absent from the multinucleated syncytiotrophoblast. Reproduction 143: 107-121.
52. Cheung AN, Ngan HY, Collins RJ, Wong YL (1994) Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. J Clin Pathol 47: 601-604.
53. Crocker IP, Tansinda DM, Jones CJ, Baker PN (2004) The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 52: 749-757. (Pubitemid 38703129)
54. DiFederico E, Genbacev O, Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155: 293-301. (Pubitemid 29318727)
55. Park JK, Kang MY, Kim YH, Jo HC, Shin JK, et al. (2008) PKC delta in preeclamptic placentas promotes Bax dissociation from 14-3-3 zeta through 14-3-3 zeta phosphorylation. Placenta 29: 584-592.
56. Cobellis L, De Falco M, Torella M, Trabucco E, Caprio F, et al. (2007) Modulation of Bax expression in physiological and pathological human placentas throughout pregnancy. In Vivo 21: 777-783.
57. Qiao S, Nagasaka T, Harada T, Nakashima N (1998) p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 19: 361-369. (Pubitemid 28327694)
58. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, et al. (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43: 119-127. (Pubitemid 28103575)
59. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, et al. (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186: 158-166. (Pubitemid 34093758)
60. Ratts VS, Tao XJ, Webster CB, Swanson PE, Smith SD, et al. (2000) Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 21: 361-366. (Pubitemid 30364870)
61. Ellery PM, Cindrova-Davies T, Jauniaux E, Ferguson-Smith AC, Burton GJ (2009) Evidence for transcriptional activity in the syncytiotrophoblast of the human placenta. Placenta 30: 329-334.
62. Ka H, Hunt JS (2003) Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 163: 413-422. (Pubitemid 36909405)
63. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
64. Rodriguez D, Rojas-Rivera D, Hetz C (2011) Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat. Biochim Biophys Acta 1813: 564-574.
65. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, et al. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939. (Pubitemid 41345209)
66. Kroemer G, Marino G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40: 280-293.
67. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305. (Pubitemid 27406646)
68. Hammond EM, Giaccia AJ (2005) The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331: 718-725. (Pubitemid 40615503)
69. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H, et al. (1999) Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest 79: 1687-1702. (Pubitemid 30013932)
70. Oren M, Maltzman W, Levine AJ (1981) Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1: 101-110. (Pubitemid 11103325)
71. Pan Y, Haines DS (1999) The pathway regulating MDM2 protein degradation can be altered in human leukemic cells. Cancer Res 59: 2064-2067. (Pubitemid 29217665)
72. Zeng Y, Cullen BR (2002) RNA interference in human cells is restricted to the cytoplasm. Rna 8: 855-860. (Pubitemid 34787682)
73. Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, et al. (2006) Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1. 26: 3473-3481.
74. Lau LM, Nugent JK, Zhao X, Irwin MS (2008) HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 27: 997-1003. (Pubitemid 351225385)
75. Chen B, Longtine MS, Sadovsky Y, Nelson DM (2010) Hypoxia down-regulates p53 but induces apoptosis and enhances expression if BAD in cultures of human syncytiotrophoblasts. Am J Physiol Cell Physiol 299: C968-976.
76. Kilani RT, Mackova M, Davidge ST, Guilbert LJ (2003) Effect of oxygen levels in villous trophoblast apoptosis. Placenta 24: 826-834. (Pubitemid 37184810)
77. Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, et al. (2005) MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 106: 3150-3159. (Pubitemid 41565913)
78. Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, et al. (2008) p53-mediated apoptosis of CLL cells: evidence for a transcription- independent mechanism. Blood 112: 3827-3834.
79. Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, et al. (2006) Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A 103: 1888-1893. (Pubitemid 43228788)
80. Vaseva AV, Marchenko ND, Moll UM (2009) The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle 8: 1711-1719.
81. Lorenzo E, Ruiz-Ruiz C, Quesada AJ, Hernandez G, Rodriguez A, et al. (2002) Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism. J Biol Chem 277: 10883-10892. (Pubitemid 34952843)
82. Drakos E, Atsaves V, Schlette E, Li J, Papanastasi I, et al. (2009) The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Leukemia 23: 2290-2299.
83. Mihara M, Erster S, Zaiko A, Petrenko O, Chittendon T, et al. (2003) p53 has a direct apoptogenic role at the mitochondria. Molecular Cell 11: 577-590. (Pubitemid 36385115)
84. Ding H, Lin YL, McGill G, Juo P, Blenis J, et al. (2000) Essential role for caspase-8 in transcription independent apoptosis triggered by p53. J Biol Chem 275: 38905-38911. (Pubitemid 32009229)
85. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, et al. (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282: 290-293. (Pubitemid 28487200)
86. Chau CC, Liu X, Gao J, Hamdy RC, Chua BH (2006) Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol 290: H2606-2613. (Pubitemid 43846092)